UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 62

Sortiert nach

Global gyrokinetic study of density gradient driven instability in tokamaks: the ubiquitous mode

Plasma physics and controlled fusion, 2024-08, Vol.66 (8), p.85013

2024

Volltextzugriff (PDF)

Molecular dynamics simulations to study the interaction between carbon nanotube and calmodulin protein

Materials today : proceedings, 2020, Vol.28, p.108-111

2020

Volltextzugriff (PDF)

Magnetic shaping effects on turbulence in ADITYA-U tokamak

Nuclear fusion, 2024-10, Vol.64 (10)

2024

Volltextzugriff (PDF)

Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria

Drug metabolism and disposition, 2013-07, Vol.41 (7), p.1347

2013

Volltextzugriff (PDF)

Small molecule allosteric inhibitors of ROR[gamma]t block Th17-dependent inflammation and associated gene expression in vivo

PloS one, 2021-11, Vol.16 (11), p.e0248034

2021

Volltextzugriff (PDF)

Molecular dynamics of Yukawa liquids in gravitation: Equilibrium, Instability and Transport

Journal of plasma physics, 2014-12, Vol.80 (6), p.895-917

2014

Volltextzugriff (PDF)

Abstract 931: Discovery of ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.931-931

2018

Volltextzugriff (PDF)

Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors

Bioorganic & medicinal chemistry letters, 2018-06, Vol.28 (10), p.1804-1810

2018

Volltextzugriff (PDF)

Assessment of the Time‐Dependent Inhibition (TDI) Potential of Test Compounds with Human Liver Microsomes by IC 50 Shift Method Using a Nondilution Approach

Current Protocols in Pharmacology, 2012-09, Vol.58 (1)

2012

Volltextzugriff (PDF)

Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor

The Journal of pharmacology and experimental therapeutics, 2011-03, Vol.336 (3), p.816

2011

Volltextzugriff (PDF)

Evaluation of Ginkgo biloba extract as an activator of human glucocorticoid receptor

Journal of ethnopharmacology, 2013-01, Vol.145 (2), p.670-675

2013

Volltextzugriff (PDF)

Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indications

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4718-4718

2016

Volltextzugriff (PDF)

Abstract 4695: Functional group elaboration of a low molecular weight fragment to yield the novel BET family bromodomain inhibitor ABBV-075

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4695-4695

2016

Volltextzugriff (PDF)

Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor

Drug metabolism and disposition, 2012-01, Vol.40 (1), p.178

2012

Volltextzugriff (PDF)

Meclizine is not an inverse agonist or antagonist of human constitutive androstane receptor

The FASEB journal, 2011-04, Vol.25 (S1), p.1014.7-1014.7

2011

Volltextzugriff (PDF)

Meclizine is an agonist of human pregnane X receptor

The FASEB journal, 2011-04, Vol.25 (S1), p.1014.5-1014.5

2011

Volltextzugriff (PDF)

A High-Throughput (HTS) Assay for Enzyme Reaction Phenotyping in Human Recombinant P450 Enzymes Using LC-MS/MS

Current protocols in pharmacology, 2014-03, Vol.64, p.9.18.1-9.1810

2014

Volltextzugriff (PDF)

Assessment of the Time‐Dependent Inhibition (TDI) Potential of Test Compounds with Human Liver Microsomes by IC50 Shift Method Using a Nondilution Approach

Current Protocols in Pharmacology, 2012-09, Vol.58 (1), p.7.14.1-7.14.13

2012

Volltextzugriff (PDF)

Differential role of ginkgolide A and bilobalide in CYP3A and CYP2B6 induction by Ginkgo biloba extract in primary cultures of human hepatocytes

The FASEB journal, 2010-04, Vol.24 (S1), p.757.6-757.6

2010

Volltextzugriff (PDF)

Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells

Canadian journal of physiology and pharmacology, 2009-09, Vol.87 (9), p.674

2009

Volltextzugriff (PDF)

Assessment of P‐Glycoprotein Substrate and Inhibition Potential of Test Compounds in MDR1‐Transfected MDCK Cells

Current Protocols in Pharmacology, 2012-09, Vol.58 (1), p.7.13.1-7.13.17

2012

Volltextzugriff (PDF)

26 – 50 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Global gyrokinetic study of density gradient driven instability in tokamaks: the ubiquitous mode

Discovery of N‑(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro‑1H‑pyrrolo[2,3‑c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor

Molecular dynamics simulations to study the interaction between carbon nanotube and calmodulin protein

Magnetic shaping effects on turbulence in ADITYA-U tokamak

Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria

Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors

Small molecule allosteric inhibitors of ROR[gamma]t block Th17-dependent inflammation and associated gene expression in vivo

Molecular dynamics of Yukawa liquids in gravitation: Equilibrium, Instability and Transport

Abstract 931: Discovery of ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor

Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors

Assessment of the Time‐Dependent Inhibition (TDI) Potential of Test Compounds with Human Liver Microsomes by IC 50 Shift Method Using a Nondilution Approach

Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions

Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor

Evaluation of Ginkgo biloba extract as an activator of human glucocorticoid receptor

Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indications

Abstract 4695: Functional group elaboration of a low molecular weight fragment to yield the novel BET family bromodomain inhibitor ABBV-075

Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor

Meclizine is not an inverse agonist or antagonist of human constitutive androstane receptor

Meclizine is an agonist of human pregnane X receptor

A High-Throughput (HTS) Assay for Enzyme Reaction Phenotyping in Human Recombinant P450 Enzymes Using LC-MS/MS

Assessment of the Time‐Dependent Inhibition (TDI) Potential of Test Compounds with Human Liver Microsomes by IC50 Shift Method Using a Nondilution Approach

Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo

Differential role of ginkgolide A and bilobalide in CYP3A and CYP2B6 induction by Ginkgo biloba extract in primary cultures of human hepatocytes

Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells

Assessment of P‐Glycoprotein Substrate and Inhibition Potential of Test Compounds in MDR1‐Transfected MDCK Cells

Suchergebnisse filtern